Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Thanks for posting this. It seems like this is a

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155037
(Total Views: 408)
Posted On: 03/11/2020 6:59:25 PM
Posted By: BlackDoggie
Re: lagrange #21073
Thanks for posting this. It seems like this is a different abstract, as the title was different, Sacha wasn't the presenter, and there's no mention of CCR5. Still, glad to see that work that Sacha was a part of is at CROI.

I'm very interested in what happened to Sacha's abstract that was PR'd back in January. Doesn't appear at this point that it made it to CROI. Hoping it's for positive reasons, but I'm wondering if the abstract got the boot for clear violations of PR rules. This is an excerpt from the PR rules on the CROI site - this provides an exception to the general rule of "no PR's until after the embargo is lifted":

“Material information” exceptions: Publicly traded companies that determine that they must disclose general findings of a research study to be presented at CROI in order to satisfy US Securities and Exchange Commission (SEC) requirements must notify the conference organizer at CROIabstracts@iasusa.org and provide a copy of their release and their distribution plans in advance. Such releases may include only general findings (not the full data to be presented at the meeting) and may not reference the Conference or the presentation by name.

The January PR clearly broke at least two of those rules, referencing both the conference and the presentation by name. If indeed that occurred, hopefully it didn't sour the relationship with Sacha as it appears that his research is promising.


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us